意大利产碳青霉烯酶肺炎克雷伯菌定植与感染的临床特征及意义
本文基于意大利多中心队列研究,分析产碳青霉烯酶肺炎克雷伯菌(KPC-Kp)的定植与感染特征。研究发现77%菌株为ST512或ST307,2017年患病率为3.26例/1000住院患者,入院48小时后获得KPC-Kp的累积发病率0.68%但中心间差异大。重症感染者15天死亡率高于轻症或定植者,轻症患者接受充分治疗延迟>4天更常见。
要点
- KPC-Kp在意大利自2013年呈地方流行,主要序列型为ST512和ST307。
- 重症感染者15天死亡率显著高于轻症感染或定植者。
- 轻症感染者接受充分治疗延迟>4天的情况更常见。
核心结论
- 重症KPC-Kp感染患者15天死亡率高于轻症感染或定植患者,轻症患者治疗延迟更常见。
- 意大利亟需协调的监测系统以控制KPC-Kp传播。
研究设计与样本
- 多中心队列研究,纳入KPC-Kp定植或感染患者,调查15天死亡率及充分治疗延迟等。
主要发现
- 77%的KPC-Kp菌株为ST512或ST307。
- 2017年KPC-Kp患病率为3.26例/1000住院患者。
- 入院>48小时后获得KPC-Kp的累积发病率为0.68%,中心间差异大。
- 轻症感染与未感染定植者的15天死亡率相当,重症感染者死亡率更高。
- 充分治疗延迟>4天在轻症感染者中比重症感染者更常见,已知既往KPC-Kp定植者延迟较少。
临床怎么用
- 对重症KPC-Kp感染应高度警惕高死亡率,尽早给予充分治疗。
- 轻症感染者亦需关注治疗延迟风险,尤其无已知定植史者。
- 需建立协调监测系统以控制KPC-Kp院内传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-Kp) has been endemic in Italy since 2013. In a multicenter cohort study, we investigated various aspects of KPC-Kp among patients, including 15-day mortality rates and delays in adequate therapy. Most (77%) KPC-Kp strains were sequence type (ST) ST512 or ST307. During 2017, KPC-Kp prevalence was 3.26 cases/1,000 hospitalized patients. Cumulative incidence of KPC-Kp acquired >48 hours after hospital admission was 0.68% but varied widely between centers. Among patients with mild infections and noninfected colonized patients, 15-day mortality rates were comparable, but rates were much higher among patients with severe infections. Delays of >4 days in receiving adequate therapy more frequently occurred among patients with mild infections than those with severe infections, and delays were less common for patients with known previous KPC-Kp colonization. Italy urgently needs a concerted surveillance system to control the spread of KPC-Kp. We found 15-day mortality rates were higher for patients with severe infections than for those with mild infections or colonization.
引用
- Rossi M, Chatenoud L, Gona F, et al. Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy. Emerg Infect Dis. 2021. PMID: 33900910. doi:10.3201/eid2705.203662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。